-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Perspective Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- Perspective Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.3M, a 46.2% decline year-over-year.
- Perspective Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$48.7M, a 97.1% decline year-over-year.
- Perspective Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$40.9M, a 372% decline from 2022.
- Perspective Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$8.67M, a 152% decline from 2021.
- Perspective Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$3.45M, a 0.86% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)